Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background. A significant part of the children’s population of Ukraine suffers from stress-related disorders, which lead to serious complications and somatic diseases, including an increased incidence of acute respiratory pathology, and create a global economic problem in the field of health care. This is a challenge for pediatric practice and requires improvement and increasing the effectiveness of rehabilitation measures, development of comprehensive therapeutic approaches. The purpose of the study: to increase the effectiveness of the rehabilitation for stress-related disorders and acute respiratory infections (ARIs) in school-age children under the conditions of martial law in Ukraine by means of synergistic pharmacological correction with the inclusion of immunocorrective and sedative agents. Materials and methods. The study included 125 children aged 6–10 years who permanently lived in the territory of Ukraine (Kyiv, Kharkiv, Lviv, Dnipro, Zaporizhzhia, Odesa, Kropyvnytskyi, Vinnytsia, Kryvyi Rih, Zhytomyr, Cherkasy, Poltava, Sumy, Berdychiv, Romny, Bila Tserkva) during the previous year. The study was carried out as part of the program of outpatient observation of children with various acute manifestations of ARIs against the background of stress damage to the nervous system due to the war in Ukraine, and taking naturopathic drugs with immunocorrective properties (scheme (1)): 1) affinity-purified antibodies to human interferon gamma (6 mg), histamine (6 mg) and CD4 (6 mg) — a mixture of homeopathic dilutions C12, C30 and C50; or in combination with a drug with a sedative effect (scheme (1+2)): 1) affinity-purified antibodies to human gamma interferon (6 mg), histamine (6 mg) and CD4 (6 mg) — a mixture of homeopathic dilutions C12, C30 and C50; 2) affinity-purified antibodies to brain-specific protein S100 (3 mg) — a mixture of homeopathic dilutions C12, C30 and C50. Statistical processing of the results was carried out using GraphPad Prism 9.0 Software for Windows (USA, San Diego, CA). Results. The synergistic therapeutic effect of the scheme (1+2) showed a significantly better impact on stress-related disorders — sleep disorders, post-traumatic stress disorder, stress-related disorders, quality of life. In addition, there was a more pronounced corrective and rehabilitative effect of the scheme (1+2) on the indicators of fever, duration of low fever, sore throat, runny nose, symptoms of bronchitis, and manifestations of respiratory infection, assessed according to the Wisconsin Questionnaire. Analysis of satisfaction with the treatment effect on the IMOS international scale during the observation period showed positive results and a high level of assessment by both doctors and parents. Conclusions. Thus, the synergy of rehabilitation for stress-related disorders and ARIs in school-age children under martial law in Ukraine with the use of immunocorrective and sedative agents has pronounced effect, both early and delayed, a high level of assessment by doctors and parents of children aged 6–10 years.
Background. A significant part of the children’s population of Ukraine suffers from stress-related disorders, which lead to serious complications and somatic diseases, including an increased incidence of acute respiratory pathology, and create a global economic problem in the field of health care. This is a challenge for pediatric practice and requires improvement and increasing the effectiveness of rehabilitation measures, development of comprehensive therapeutic approaches. The purpose of the study: to increase the effectiveness of the rehabilitation for stress-related disorders and acute respiratory infections (ARIs) in school-age children under the conditions of martial law in Ukraine by means of synergistic pharmacological correction with the inclusion of immunocorrective and sedative agents. Materials and methods. The study included 125 children aged 6–10 years who permanently lived in the territory of Ukraine (Kyiv, Kharkiv, Lviv, Dnipro, Zaporizhzhia, Odesa, Kropyvnytskyi, Vinnytsia, Kryvyi Rih, Zhytomyr, Cherkasy, Poltava, Sumy, Berdychiv, Romny, Bila Tserkva) during the previous year. The study was carried out as part of the program of outpatient observation of children with various acute manifestations of ARIs against the background of stress damage to the nervous system due to the war in Ukraine, and taking naturopathic drugs with immunocorrective properties (scheme (1)): 1) affinity-purified antibodies to human interferon gamma (6 mg), histamine (6 mg) and CD4 (6 mg) — a mixture of homeopathic dilutions C12, C30 and C50; or in combination with a drug with a sedative effect (scheme (1+2)): 1) affinity-purified antibodies to human gamma interferon (6 mg), histamine (6 mg) and CD4 (6 mg) — a mixture of homeopathic dilutions C12, C30 and C50; 2) affinity-purified antibodies to brain-specific protein S100 (3 mg) — a mixture of homeopathic dilutions C12, C30 and C50. Statistical processing of the results was carried out using GraphPad Prism 9.0 Software for Windows (USA, San Diego, CA). Results. The synergistic therapeutic effect of the scheme (1+2) showed a significantly better impact on stress-related disorders — sleep disorders, post-traumatic stress disorder, stress-related disorders, quality of life. In addition, there was a more pronounced corrective and rehabilitative effect of the scheme (1+2) on the indicators of fever, duration of low fever, sore throat, runny nose, symptoms of bronchitis, and manifestations of respiratory infection, assessed according to the Wisconsin Questionnaire. Analysis of satisfaction with the treatment effect on the IMOS international scale during the observation period showed positive results and a high level of assessment by both doctors and parents. Conclusions. Thus, the synergy of rehabilitation for stress-related disorders and ARIs in school-age children under martial law in Ukraine with the use of immunocorrective and sedative agents has pronounced effect, both early and delayed, a high level of assessment by doctors and parents of children aged 6–10 years.
Bacterial Lysates are immunostimulants clinically prescribed for the prevention of respiratory tract infections (RTIs). It has been shown that Bacterial Lysates upregulate the immune system, acting both on innate and adaptive reactions. In fact, there are demonstrations of their efficacy in restoring the integrity and immune function of epithelial barriers, activating ILC3 and dendritic cells with an enhanced Th1 response, and producing serum IgG and serum and salivary IgA specific to the administered bacterial antigens. The activated immune system also protects against other bacteria and viruses due to a trained immunity effect. Most studies show that the number of RTIs and their severity decrease in Bacterial Lysates-pretreated patients, without relevant side effects. The Bacterial Lysates treatment, in addition to reducing the number of RTIs, also prevents the deterioration of the underlying disease (i.e., COPD) induced by repeated infections. Despite these positive data, the most recent meta-analyses evidence the weakness of the studies performed, which are of low quality and have an inadequate number of patients, some of which were non-randomized while others were without a control group or were performed contemporarily in different clinical conditions or with different ages. The high heterogeneity of the studies does not allow us to state Bacterial Lysates’ effectiveness in preventing RTIs with sufficient certainty. To completely define their indications, double-blind, placebo-controlled, multicenter, randomized clinical trials should be performed for each product and for each indication. The study population should be adequate for each indication. For this purpose, an adequate run-in phase will be necessary.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.